Article citationsMore>>
Furuta, T., Sugimoto, M., Yamade, M., Uotani, T., Sahara, S., Ichikawa, H., Yamada, T., Osawa, S., Sugimoto, K., Watanabe, H. and Umemura, K. (2014) Effect of Dosing Schemes of Amoxicillin on Eradication Rates of Helicobacter pylori with Amoxicillin-Based Triple Therapy. The Journal of Clinical Pharmacology, 54, 258-266.
https://doi.org/10.1002/jcph.195
has been cited by the following article:
-
TITLE:
Gastric Mucosal Atrophy Might Be Associated with the Efficacy of First-Line Therapy Using Vonoprazan for Helicobacter pylori
AUTHORS:
Mika Miura, Masahiko Ohtaka, Mitsuhiko Hanawa, Naoki Shimura, Yoshioki Yoda, Sho Suzuki
KEYWORDS:
Vonoprazan, Eradication, Helicobacter pylori, Propensity Score Matching, Gastric Mucosal Atrophy
JOURNAL NAME:
Open Journal of Gastroenterology,
Vol.7 No.9,
September
28,
2017
ABSTRACT: Aim: To investigate the factors related to the effect of eradication therapy with vonoprazan for Helicobacter pylori (H. pylori). Methods: We retrospectively reviewed medical records of H. pylori-positive patients who received first-line (40 mg vonoprazan/60 mg lansoprazole or 20 mg rabeprazole, 1500 mg amoxicillin, 400 mg clarithromycin, all 2/day for 7 days) (n = 4118). H. pylori eradication was assessed by the 13C-urea breath test with success defined as a result of H. pylori eradication therapy using vonoprazan was more effective than standard triple therapy with proton pump inhibitor. Gastric mucosal atrophy was associated with treatment success.
Related Articles:
-
Valerii Ermakov, Volodymyr Kolomoets, Leonid Panasyuk, Baja Orasgulyev
-
Yuka Satoh, Hatsue Ogawara, Osamu Kawamura, Yasuyuki Shimoyama, Motoyasu Kusano, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Norifumi Tsukamoto, Hirokazu Murakami
-
Daniel T. Cassidy
-
Masahiko Ohtaka, Mika Miura, Mitsuhiko Hanawa, Yuichi Hirose, Atsuko Kitahashi, Naoki Imamura, Ikko Watanabe, Kazuhiko Takaso, Naoki Shimura, Yoshioki Yoda, Ichiro Takayama, Mitsuharu Fukasawa, Nobuyuki Enomoto
-
Daoling Fu, Ming Yang, Jindong Chang